Transboundary and Emerging Diseases

期刊简介：Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.

【译文】跨边界和新兴疾病汇集了关于全球动物和人类面临最大经济威胁的传染病的最新研究。该期刊提供了一个全球研究其诊断、预防和管理的平台，以及关于公共卫生、发病机制、流行病学、统计建模、诊断、生物安全问题和基因组学、疫苗开发以及新疫情快速通讯的论文。论文应包括使用最先进技术的及时研究方法。编辑鼓励采用基于科学的论文，探讨影响这些疾病生物安全威胁管理的社会经济和环境因素，包括风险评估和疾病传播建模。优先考虑关注控制跨边界和新兴疾病的创新科学方法的通讯。以下主题通常被认为超出了范围，但会根据具体情况做出决定（例如，关于隐秘野生动物种群的研究，以及关于潜在物种灭绝的研究）：病原体发现：在特定国家新发现的常见病原体，或对出现或传播缺乏背景或洞察的新病原体或基因序列。基于调查（而不是纵向）方法进行的流行病学估计调查和风险因素研究，除非这些研究是独特的。关于知识、态度和实践的调查在范围内。如果没有伴随来自现场研究的稳健灵敏度和特异性估计，则诊断测试开发不在范围内。仅关注实验室方法的研究，其中与疾病出现和传播的相关性不明显或无法推断（“纯研究”类型的研究）。不产生新知识的叙述性文献综述。系统评价和范围评价，以及荟萃分析在范围内。